TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM

Patrick Neven, X. De Muylder, Yves Van Belle, G. Vanderick, E. De Muylder, HelenJ. Stewart, GillianM. Knight, Antonio Cano, Pilar Matallı́n, V. Legua, Miguel Tortajada, Fernando Bonilla‐Musoles
In: The Lancet · 1989 · vol. 333(8634) , pp. 375–376 · doi:10.1016/s0140-6736(89)91741-8 · PMID:18446929 · W2127828646
article OA: closed CC0 ⤵ 34 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This paper reviews the effects of tamoxifen on the uterus and endometrium, focusing on observed changes and potential clinical implications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (17)

Cited by (31)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-08T06:33:43.470499+00:00
License: CC0 · commercial use OK